FI791638A - Bensylpyrimidinkompositioner - Google Patents

Bensylpyrimidinkompositioner

Info

Publication number
FI791638A
FI791638A FI791638A FI791638A FI791638A FI 791638 A FI791638 A FI 791638A FI 791638 A FI791638 A FI 791638A FI 791638 A FI791638 A FI 791638A FI 791638 A FI791638 A FI 791638A
Authority
FI
Finland
Prior art keywords
compositioner
benzylpyrimidine
benzylpyrimidine compositioner
Prior art date
Application number
FI791638A
Other languages
English (en)
Inventor
Stanley Robert Morris Bushby
James Joseph Burchall
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI791638A publication Critical patent/FI791638A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/63Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI791638A 1978-05-24 1979-05-23 Bensylpyrimidinkompositioner FI791638A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2193878 1978-05-24

Publications (1)

Publication Number Publication Date
FI791638A true FI791638A (fi) 1979-11-25

Family

ID=10171323

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791638A FI791638A (fi) 1978-05-24 1979-05-23 Bensylpyrimidinkompositioner

Country Status (12)

Country Link
EP (1) EP0006987A1 (fi)
JP (1) JPS54154775A (fi)
AU (1) AU4732579A (fi)
DK (1) DK214479A (fi)
FI (1) FI791638A (fi)
IL (1) IL57375A0 (fi)
IT (1) IT1117752B (fi)
MA (1) MA18450A1 (fi)
MC (1) MC1264A1 (fi)
NO (1) NO791699L (fi)
PT (1) PT69656A (fi)
ZW (1) ZW9979A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA818204B (en) * 1980-11-27 1983-07-27 Wellcome Found Antibacterial benzylpyrimidines
HU188588B (en) * 1982-08-13 1986-04-28 Egyt Gyogyszervegyeszeti Gyar Process for the production of 2,4-diamino-5-benzyl-pyrimidine-derivatives
FR2652812A1 (fr) * 1989-10-09 1991-04-12 Rhone Poulenc Chimie Procede de preparation de difluoro-2,2 benzodioxole-1,3.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB875562A (en) * 1957-02-21 1961-08-23 Wellcome Found Improvements in and relating to pyrimidine derivatives and the preparation thereof
GB1128234A (en) * 1966-02-19 1968-09-25 Wellcome Found 5-benzylpyrimidine derivatives and process for the preparation thereof
CH544053A (de) * 1966-05-09 1973-11-15 Hoffmann La Roche Verfahren zur Herstellung von Sulfonamidderivaten
US3684810A (en) * 1970-03-11 1972-08-15 Hoffmann La Roche Process for 2,4-diamino-5-(3,5-dimethoxy-4-hydroxybenzyl) pyrimidine
GB1375162A (fi) * 1970-10-22 1974-11-27
BE789904A (fr) * 1971-10-12 1973-04-10 Wellcome Found Procedes de synthese organique
GB1413472A (en) * 1971-10-12 1975-11-12 Wellcome Found 2,4-diamino pyrimidines
DE2546667C3 (de) * 1975-10-17 1978-10-12 Ludwig Heumann & Co Gmbh, 8500 Nuernberg 2,4-DiamüH»-5-(3-methoxy-4-hydroxy-5-halogenbenzyl)-pyrimidine, und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
AU4732579A (en) 1979-11-29
NO791699L (no) 1979-11-27
DK214479A (da) 1979-11-25
PT69656A (en) 1979-06-01
MC1264A1 (fr) 1980-03-28
EP0006987A1 (en) 1980-01-23
JPS54154775A (en) 1979-12-06
IL57375A0 (en) 1979-09-30
MA18450A1 (fr) 1979-12-31
ZW9979A1 (en) 1980-12-24
IT1117752B (it) 1986-02-24
IT7949150A0 (it) 1979-05-23

Similar Documents

Publication Publication Date Title
AT379079B (de) Akupunkturgeraet
AT370950B (de) Hoeschenwindel
BE875475A (fr) Iminoquinazolines
BE872071A (fr) Afdichtorgaan
AT365922B (de) Netzbett
BE876254A (fr) Omsluitingsinrichting
BE874159A (fr) Thermoplongeur
BE878030A (fr) Snelle informatieschakelaar
BE876344A (fr) Snelkoppelend kogelscharnier
AT374352B (de) Sportschuh
BE876059A (fr) Azolopyrimidinones
BE873461A (fr) Kleerhanger
AR218561A1 (es) Copoliester p-oxibenzoilico
BE877468A (fr) Recolteuse-hacheuse
BE877955A (fr) Alkylthiophenoxyalkylamines
ATA872778A (de) Uhrband
ATA26879A (de) B-ettbank
AT368010B (de) Rollskier
FI793693A (fi) Suglaoda
BE871213R (fr) Arylmalonamido-1-oxadethiacephalosporines
FI790138A (fi) Kombinerad underlagsgjutningsapparat foer betong
FI791117A (fi) Kuvertenheter
AR224881A1 (es) 2-hidroxifenilbenzotiazoles
AT355471B (de) Schipresse
AT357332B (de) Fraeser

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED